ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

MIR4435-2HG: A Tumor-associated Long Non-coding RNA

Zhao, Fangnan; Liu, Yuling; Tan, Fangshun; Tang, Lu; Du, Zhuoying; Mou, Jie; Zhou, Gang*; Yuan, Chengfu*china three gorges univ
Current Pharmaceutical Design2022DOI: 10.2174/1381612828666220607100228
2被引20阅读
引用收藏
分享

摘要

Background: It is well known that the changes in the expression level of LncRNA can affect the progression of tumors, which has caused a great upsurge of research in recent years. Several LncRNAs have been identified to affect a series of cancers and can promote tumor growth, migration, and invasion. In this \nreview, we aim to clarify the pathophysiological functions of LncRNA MIR4435-2 HG in multiple tumors. Methods: By searching the literature through PubMed, this paper summarizes the relationship between MIR4435-2HG and tumor and its role in the occurrence and development of cancer and also explains the specific molecular mechanism of the effect of MIR4435-2HG on cancer. Results: MIR4435-2HG can function as an oncogene in a variety of cancers. The expression level was reported to be abnormally elevated in a series of cancers, consisting of melanoma, gastric cancer, head and neck squamous cell carcinoma, oral squamous cell carcinoma, lung cancer, cervical cancer, prostate carcinoma, ovarian cancer, breast cancer, hepatocellular carcinoma, clear cell renal cell carcinoma malignant, glioma, and colorectal cancer. Moreover, MIR4435-2HG is related to the poor prognosis of a variety of cancers. MIR4435-2HG can also affect tumor proliferation, invasion, and apoptosis. In addition, MIR4435-2HG can also enhance the metabolic function of myeloid dendritic cells of elite HIV-1 controllers. Conclusion: MIR4435-2HG affects the development of a variety of cancers. It can act as a clinical marker for early tumor diagnosis and affects tumor-targeted therapy.

学科与关键词

关键词
LncRNAMIR4435-2HGtumorbiomarkerstherapeutic targetdiagnosis
相关
加载中…
  • MIR17HG: A Cancerogenic Long-Noncoding RNA in Different Cancers
    Tan, Fangshun; Chen, Jinlan; Du, Zhuoying; Zhao, Fangnan; Liu, Yuling; Zhang, Qi; Yuan, Chengfu*Current Pharmaceutical Design, 2022, 28(15): 1272-1281.被引 5
  • LncmiRHG-MIR100HG: A new budding star in cancer
    Wu, Yingnan; Wang, Zhenzhen; Yu, Shan; Liu, Dongzhe*; Sun, Litao*Frontiers in Oncology, 2022, 12: 997532.被引 6
  • Long noncoding RNA MIR210HG is induced by hypoxia-inducible factor 1α and promotes cervical cancer progression
    Hu, Xiao-Lin; Huang, Xia-Tong; Zhang, Jia-Ni; Liu, Jie; Wen, Li-Jun; Xu, Xin; Zhou, Jue-Yu*American Journal of Cancer Research, 2022, 12(6): 2783-+.被引 5
查看全部 →

发表信息

论文状态
公开发表
期刊
Current Pharmaceutical Design
发表日期
2022
卷期
第 28 卷, 第 25 期
页码
2043-2051
DOI
10.2174/1381612828666220607100228
语言
ENGLISH
期刊等级
4区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81974528, 82174035, 81773959]; Hubei Province Natural Science Foundation in China [2021CFA015]; central government guides the special funds for the development of local science and technology [2020ZYYD016]; Health commission of Hubei Province scientific research project in China [WJ2019H527]

作者

  • Z

    Zhao, Fangnan (第一作者)

    china three gorges univ

  • L

    Liu, Yuling

    china three gorges univ

查看全部 8 位作者收起作者
  • T

    Tan, Fangshun

    china three gorges univ

  • T

    Tang, Lu

    china three gorges univ

  • D

    Du, Zhuoying

    china three gorges univ

  • M

    Mou, Jie

    china three gorges univ

  • Z

    Zhou, Gang (通讯)

    china three gorges univ

  • Y

    Yuan, Chengfu (通讯)

    china three gorges univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417